(MedPage Today) — The FDA approved a pill version of the GLP-1 receptor agonist semaglutide (Wegovy), making it the first oral GLP-1 agent indicated for weight loss, Novo Nordisk announced on Monday.
The once-daily 25 mg pill is approved to lower…
She previously shared her secrets to her timeless look, saying she drinks an apple concoction and uses coffee grounds mixed...
The fall in power-sector emissions is particularly notable, given it was the largest driver of emissions increases in 2021-2023, responsible...
Justice Prathiba M. Singh, who is hearing a bunch of petitions by rare disease patients and their parents to provide...
Dr. Reddy succeeds Ameera Shah, promoter and executive chairperson, Metropolis Healthcare Ltd. Source: www.thehindu.com Medical Disclaimer: This content is shared...
Shigellosis is one of the leading bacterial causes of diarrhoea worldwide. Source: www.thehindu.com Medical Disclaimer: This content is shared for...
Ever wondered why some illnesses are able to affect us only once? Source: www.thehindu.com Medical Disclaimer: This content is shared...
